BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Betamethasone valerate 0.1% oint 12.5% in WSP 1304000F0AAFQFQ	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 20% in Emulsifying oint 1304000F0AACXCX	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 20% in Gen Unguentum M crm 1304000F0AAEUEU	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 20% in White soft paraffin 1304000F0AADXDX	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25% in Emulsifying oint 1304000F0AAFGFG	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25% in Gen Unguentum M crm 1304000F0AAFJFJ	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25% in White soft paraffin 1304000F0AADNDN	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25%/Coal tar soln 5% in WSP 1304000F0AAESES	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25%/Coal tar soln 6% in WSP 1304000F0AAENEN	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 25%/Ichthammol 1% in YSP 1304000F0AAEMEM	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 30%/Coal tar soln 5% in YSP 1304000F0AAFIFI	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 33% in White soft paraffin 1304000F0AADVDV	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 40% in White soft paraffin 1304000F0AADYDY	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 5% in White soft paraffin 1304000F0AACTCT	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 50% in Emulsifying oint 1304000F0AACNCN	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% oint 50% in Yellow soft paraffin 1304000F0AADZDZ	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Aqueous cream 1304000F0AAFRFR	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Coal tar paste 1304000F0AAEHEH	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betamethasone valerate 0.1% ointment 50% in Hydrous ointment 1304000F0AADADA	Betamethasone valerate (Topical)	Betamethasone valerate	Skin	No data available
Betaxolol 20mg tablets 0204000G0AAAAAA	Betaxolol hydrochloride	Betaxolol hydrochloride	Cardiovascular System	No data available
Betesil 2.25mg medicated plasters (Genus) 1304000F0BFAADW	Betesil	Betamethasone valerate	Skin	No data available
Bethanechol chloride 1.8mg/5ml oral liquid 0704010C0AAADAD	Bethanechol chloride	Bethanechol chloride	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Bethanechol chloride 10mg/5ml oral liquid 0704010C0AAAEAE	Bethanechol chloride	Bethanechol chloride	Obstetrics, Gynaecology and Urinary-Tract Disorders	No data available
Betim 10mg tablets 0204000V0BBAAAA	Betim	Timolol	Cardiovascular System	No data available
Betnelan 500microgram tablets 0603020B0BBAAAB	Betnelan	Betamethasone	Endocrine System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.